Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The company reported a revenue of 4.921 billion yuan in 2024, a year-on-year decrease of 4.7%, and a net loss attributable to shareholders of 917.29 million yuan, compared to a net profit of 13.22 million yuan in 2023 [7] - The company is actively exploring new business models and has seen a significant increase in franchise operations, with 345 franchise stores by the end of 2024, an increase of 264 stores [7] - The company aims to focus on a health-oriented strategy and explore new store formats, such as "Green stores," in 2025 [7] Financial Performance Summary - Total revenue for 2023 was 5.164 billion yuan, with a year-on-year growth of 20.33% [1] - The forecast for total revenue is adjusted to 5.182 billion yuan for 2025 and 5.268 billion yuan for 2026, with expected growth rates of 5.29% and 1.66% respectively [7] - The net profit forecast for 2025 is adjusted to a loss of 127.96 million yuan, with a projected recovery to a profit of 5.23 million yuan in 2026 and 56.48 million yuan in 2027 [7] - The company’s average customer transaction value decreased by 9.8% to 26.7 yuan, and the average daily order volume per store fell by 21.4% to 270.5 orders [7] Market Data - The closing price of the stock is 1.04 HKD, with a market capitalization of approximately 1.776 billion HKD [5] - The price-to-book ratio is 0.45, indicating the stock is trading below its book value [5] - The company has a debt-to-asset ratio of 36.48%, suggesting a moderate level of leverage [6]
奈雪的茶（02150）：2024年报点评：短期调整致业绩承压，持续探索新模式